Tradestie Institutional Equity Comparison Engine

SRZN vs LEXX โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

SRZN Overall Edge

SRZN Captures Institutional Edge (2โ€“1 Pillars ยท 7โ€“0 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Surrozen, Inc. Common (SRZN) driven by superior Growth & Margin, Options & Structure while LEXX counters with relative strength in Momentum & Technical. Fundamentally, SRZN trades at N/M Forward P/E with -485.4% operating margin (+408.6% YoY revenue) versus LEXX at N/M Forward P/E and -3862.9% operating margin (-88.5% YoY). In options structure, SRZN sits in CONSOLIDATION (5th %ile IV; Dealer Gamma Walls on Pro) against LEXX sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
SRZN N/M vs LEXX N/M Fwd P/E
Growth & Margin Winner SRZN
Op Margin -485.4% vs -3862.9% ยท YoY +408.6% vs -88.5%
Momentum & Technical Winner LEXX
1Y +166.7% vs +300.9% ยท 52W Pos 79% vs 29%
Options & Structure Winner SRZN
CONSOLIDATION (5th %ile IV) vs UNCLASSIFIED (N/A IV)
SRZN NASDAQ
Surrozen, Inc. Common
Biological Products, (No Disgnostic Substances)
$32.32
+2.25% 1D
Market Cap $602.5M
1M Return +37.88%
1Y Return +166.67%
Forward P/E N/M
Unified AI Score
34.3 / 100 SELL
Tech 5.0 Fund 32.0 Flow 65.0 Mom 40.0
LEXX NASDAQ
Lexaria Bioscience Corp. Common Stock
Pharmaceutical Preparations
$4.41
-0.68% 1D
Market Cap $9.4M
1M Return +54.2%
1Y Return +300.91%
Forward P/E N/M
Unified AI Score
33.3 / 100 SELL
Tech 50.0 Fund 30.0 Flow 50.0 Mom 50.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: SRZN +166.67% LEXX +300.91% Spread: +134.24 pp (LEXX Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period SRZN Revenue LEXX Revenue SRZN Op. Margin LEXX Op. Margin Margin Edge
FY2018 N/A $0M N/A -1525.4% LEXX
FY2019 N/A $0M N/A -1868.0% LEXX
FY2020 N/A $0M N/A -1062.2% LEXX
FY2021 N/A $0M N/A -786.8% LEXX
FY2022 $10M $0M -354.7% -2591.7% SRZN
FY2023 N/A $0M N/A -2888.5% LEXX
FY2024 $10M $0M -239.7% -1239.2% SRZN
FY2025 $0M $0M -1210.6% -1683.0% SRZN

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: SRZN (7) vs LEXX (0)
Institutional Metric SRZN LEXX Criterion Row Winner
Market Capitalization Scale $602.5M $9.4M Larger Scale SRZN
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth +408.6% -88.5% Higher Growth SRZN
Operating Margin (TTM) Profitability -485.4% -3862.9% Higher Margin SRZN
Net Profit Margin Profitability 0.0% 0.0% Higher Margin Tie
Return on Equity (ROE) Capital Efficiency -62.8% -162.8% Higher ROE SRZN
52-Week Range Position Momentum 79% ($12โ€“$38) 29% ($0โ€“$14) Stronger Trend SRZN
Beta / 30D Volatility Risk Regime 1.21ฮฒ ยท 62% Vol 11.09ฮฒ ยท 92% Vol Lower Realized Risk SRZN
Unified Institutional Score Composite Signal 34.3 / 100 (SELL) 33.3 / 100 (SELL) Higher Composite SRZN

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full SRZN vs LEXX Buy Guide
SRZN CONSOLIDATION
37d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 5th %ile
IV Regime Compressed (<25th %ile)
Live SRZN Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
LEXX UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live LEXX Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither SRZN nor LEXX registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.